Regenerative medicine in the treatment of idiopathic pulmonary fibrosis: current position
Diana Álvarez,1,2 Melanie Levine,1 Mauricio Rojas1–3 1Dorothy P and Richard P Simmons Center for Interstitial Lung Disease, 2Pulmonary, Allergy, and Critical Care Medicine, 3McGowan Institute for Regenerative Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA...
Guardado en:
Autores principales: | Álvarez D, Levine M, Rojas M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/517cbed9b1b74d7584fd16df60f4dc27 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Epigenetic modifications of embryonic stem cells: current trends and relevance in developing regenerative medicine
por: Henry Chung, et al.
Publicado: (2008) -
Regulators of pluripotency and their implications in regenerative medicine
por: El-Badawy A, et al.
Publicado: (2015) -
From regenerative dentistry to regenerative medicine: progress, challenges, and potential applications of oral stem cells
por: Xiao L, et al.
Publicado: (2014) -
Hepatic progenitors for liver disease: current position
por: Alice Conigliaro, et al.
Publicado: (2010) -
Potential sources of stem cells as a regenerative therapy for Parkinson's disease
por: Abir Oueida El-Sadik
Publicado: (2010)